|
Volumn 94 Suppl 3, Issue , 2011, Pages
|
Childhood myasthenia gravis: clinical features and outcomes.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
CHOLINESTERASE INHIBITOR;
PREDNISONE;
PYRIDOSTIGMINE;
ADOLESCENT;
ARTICLE;
CHILD;
DRUG EFFECT;
EXTRAOCULAR MUSCLE;
FEMALE;
FOLLOW UP;
HOSPITAL;
HUMAN;
MALE;
MYASTHENIA GRAVIS;
ONSET AGE;
OPHTHALMOPLEGIA;
PRESCHOOL CHILD;
PTOSIS;
RETROSPECTIVE STUDY;
SEX RATIO;
TREATMENT OUTCOME;
ADOLESCENT;
AGE OF ONSET;
ANTI-INFLAMMATORY AGENTS;
BLEPHAROPTOSIS;
CHILD;
CHILD, PRESCHOOL;
CHOLINESTERASE INHIBITORS;
FEMALE;
FOLLOW-UP STUDIES;
HOSPITALS, PEDIATRIC;
HUMANS;
MALE;
MYASTHENIA GRAVIS;
OCULOMOTOR MUSCLES;
OPHTHALMOPLEGIA;
PREDNISONE;
PYRIDOSTIGMINE BROMIDE;
RETROSPECTIVE STUDIES;
SEX DISTRIBUTION;
TREATMENT OUTCOME;
|
EID: 84856346823
PISSN: 01252208
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (0)
|